Yishan Zhou | Cardiology | Most Reader’s Article Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Yishan Zhou | Cardiology | Most Reader's Article Award

The Seventh Clinical College of Guangzhou University of Chinese Medicine | China

Ms. Zhou Yishan is a dedicated researcher in Chinese Internal Medicine whose academic and professional journey reflects consistent excellence and a strong commitment to advancing integrative medical practice. She earned her Bachelor of Medicine in Clinical Medicine (Integrated Chinese and Western Medicine) from Guangzhou Medical University, followed by a Master of Medicine in Chinese Internal Medicine (Nephrology) from Guangzhou University of Chinese Medicine. During her postgraduate studies, she served as a core project member in the Sanming Project of Medicine in Shenzhen, contributing to research initiatives focused on clinical nephrology. She also played a key role in the Baoan District Association of Chinese Medicine Promotion Project, working on the clinical evaluation of the Yiqi Huoxue Fumigation-Wash formula for preventing early failure of autogenous arteriovenous fistulas, demonstrating her commitment to improving patient outcomes through evidence-based traditional therapies. Earlier in her academic career, she served as a Research Assistant at the National Center for Respiratory Medicine, supporting Professor Sun’s team through data collection, literature reviews, and preparation of research materials, which strengthened her multidisciplinary foundation. Her achievements have been recognized through honors such as Outstanding Graduate and University Merit Student, along with multiple First-Class and Second-Class Scholarships. With 2 published documents, 11 citations, and an h-index of 1, Ms. Zhou continues to build a promising research profile grounded in rigorous clinical investigation and integrative medical innovation.

Profile: Scopus

Featured Publications

Zhou, Y., Zou, Y., Cao, Y., et al. (2025). The association between the cardiometabolic index and hyperuricemia: 2011–2016 NHANES. Frontiers in Endocrinology, 16, 1545968.

Cao, Y., Zhou, Y., Zhong, Y., Liao, X., Chen, X., & Pi, Y. (2024). Association between oxidative balance score in adults with and without chronic kidney disease: 2011–2028 NHANES. Frontiers in Nutrition, 11, 1374719.

Zhou, Y., et al. (2025). Clinical observation on Yiqi Huoxue Fumigation-Wash Formula for preventing early failure of autogenous arteriovenous fistula. Guiding Journal of Traditional Chinese Medicine and Pharmacy, 31(08), 114–120, 127.

Zhou, Y., et al. (2024). Exploration on the clinical application of Ephedrae Herba in stimulating Yang Qi. Journal of Guangzhou University of Traditional Chinese Medicine, 41(01), 234–239.

Hajime Kataoka | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Hajime Kataoka | Heart Failure | Best Researcher Award

Nishida Hospital | Japan

Dr. Hajime Kataoka is a distinguished Cardiologist and Physician-Scientist at Nishida Hospital, Oita, Japan, widely recognized for his pioneering contributions to cardiovascular medicine. He has devoted his career to advancing the understanding, diagnosis, and treatment of cardiovascular diseases, with particular expertise in clinical electrocardiography and heart failure. His research focuses on body fluid status and cardio-renal interactions in patients with heart failure, exploring how electrolyte balance influences cardiac function and disease progression. Dr. Kataoka is best known for developing the groundbreaking “chloride theory” of heart failure pathophysiology, which redefines traditional perspectives by emphasizing chloride’s key role in regulating body fluid distribution and congestion, surpassing the conventional sodium-based understanding. This innovative theory has significantly influenced modern approaches to assessing diuretic response, predicting prognosis, and optimizing treatment strategies in heart failure management. With 107 published documents, 1,101 citations from 816 citing documents, and an h-index of 19, Dr. Kataoka has made a lasting impact on cardiovascular research and clinical practice. His scientific insights continue to inspire new investigations into electrolyte physiology, fluid regulation, and therapeutic innovation, solidifying his reputation as a thought leader in contemporary cardiology and as a driving force behind transformative advances in the field.

Profiles: Scopus | Orcid

Featured Publications

Kataoka, H. (2023). Acetazolamide as a potent chloride-regaining diuretic: Time to re-evaluate its diverse actions. Polish Archives of Internal Medicine.

Kataoka, H. (2022). Estimation of plasma renin activity on the basis of serum and urinary chloride concentrations versus sodium concentrations. Cardiorenal Medicine.

Kataoka, H. (2022). Mechanistic insights into chloride-related heart failure progression according to the plasma volume status. ESC Heart Failure.

Kataoka, H. (2020). Comparison of changes in plasma volume and renal function between acetazolamide and conventional diuretics: Understanding the mechanical differences according to their effects. Cardiology.

Kataoka, H., & Yoshida, Y. (2020). Enhancement of the serum chloride concentration by administration of sodium-glucose cotransporter-2 inhibitor and its mechanisms and clinical significance in type 2 diabetic patients: A pilot study. Diabetology & Metabolic Syndrome.

Xinke Wang | Heart Failure | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Ms. Xinke Wang | Heart Failure | Best Researcher Award

China Medical University | China

Ms. Xinke Wang is a dedicated researcher and master’s scholar at China Medical University, specializing in cardiovascular diseases with a particular focus on heart failure. Her academic background integrates clinical and epidemiological research, emphasizing the translation of basic scientific discoveries into effective clinical applications. Through her work, she strives to elucidate novel mechanisms underlying heart failure progression and identify innovative therapeutic strategies to improve patient care and outcomes. Ms. Wang has contributed significantly to various aspects of research, including data curation, conceptualization, methodology design, software development, formal analysis, validation, and manuscript preparation. Her ability to bridge clinical insight with analytical expertise underscores her commitment to advancing cardiovascular medicine. Collaborating with esteemed institutions such as Kailuan General Hospital, she actively engages in multidisciplinary research aimed at improving diagnostic precision and treatment efficacy in heart failure management. Her growing body of work reflects both academic rigor and practical relevance, contributing to the evolving landscape of cardiovascular research. Ms. Wang’s scholarly efforts exemplify a strong dedication to medical innovation, evidence-based practice, and collaborative science. By combining her expertise in epidemiology with a passion for clinical application, she continues to advance the understanding of cardiovascular health and disease, fostering new approaches that hold promise for enhancing patient outcomes and shaping the future of cardiovascular research.

Profile: Orcid

Featured Publication

Wang, X., Ning, N., Li, Y., Huang, R., Liu, Y., Miao, Y., Zhang, W., Chen, S., Gao, J., Wu, S., et al. (2025). Association of scores on the Life’s Essential 8 scale with progression to type 2 diabetes, heart failure, and death: A multistate Markov model analysis. Maturitas.

Yifan Zhou | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Yifan Zhou | Cardiovascular Disease | Best Researcher Award

Hunan Normal University | China

Dr. Yifan Zhou is a dedicated researcher in the field of orthopedics, with a strong focus on musculoskeletal health, metabolic regulation, and their interrelated effects on chronic diseases. Affiliated with prominent medical institutions in China, he has made meaningful contributions to understanding how metabolic and physiological factors influence skeletal muscle mass, body composition, and overall health outcomes. He has published 3 scientific documents, achieving an h-index of 1 and a total of 4 citations from 4 referencing sources, reflecting the growing recognition of his work within the scientific community. His studies have explored key associations such as the relationship between the metabolic score for visceral fat index and skeletal muscle mass, the role of the cardiometabolic index in obstructive sleep apnea, and the link between liver function indicators and sarcopenia among middle-aged adults. Additionally, his work examines the connection between the triglyceride-glucose index and depression, highlighting the mediating effects of hypertension and smoking in obese individuals. His research has been published in respected journals including Lipids in Health and Disease, Frontiers in Endocrinology, Frontiers in Nutrition, and the Journal of Affective Disorders. Beyond his research, he also contributes as a reviewer for major international journals such as Scientific Reports, European Spine Journal, BMC Public Health, and European Journal of Medical Research.

Profiles: Scopus | Orcid

Featured Publications

Zhou, Y., Su, X., Tan, H., & Xiao, J. (2024). Association between metabolic score for visceral fat index and BMI-adjusted skeletal muscle mass index in American adults. Lipids in Health and Disease.

Zhou, Y., Yu, J., Tan, H., & Xiao, J. (2024). Association between cardiometabolic index and obstructive sleep apnea and the mediating role of smoking: A cross-sectional study. Frontiers in Endocrinology (Lausanne).

Zhou, Y., Yu, J., Wu, A., Tan, H., & Xiao, J. (2024). Association between albumin–bilirubin score and sarcopenia in middle-aged Americans: A cross-sectional study. Frontiers in Nutrition.

Zhou, Y., Yu, J., Qi, L., Tan, H., & Xiao, J. (2024). Association between triglyceride–glucose index and depression and the mediating role of hypertension: A cross-sectional study of obese adults. Journal of Affective Disorders.

Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Zhihui Zhang | Cardiovascular Research | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Zhihui Zhang | Cardiovascular Research | Best Researcher Award

Prof. Zhihui Zhang, Army Medical University, China

Prof. Zhihui Zhang is a distinguished researcher at Army Medical University, China, specializing in cardiovascular diseases and stem cell therapy. His work focuses on endothelial seed cells, myocardial infarction, and immunosuppressive capabilities of mesenchymal stem cell-derived extracellular vesicles. He has published extensively in leading journals such as Genes and Diseases, Science Bulletin, and Stem Cell Research and Therapy. Prof. Zhang’s research contributes to advancing early diagnosis and targeted interventions for coronary microvascular dysfunction. His expertise in molecular biology and regenerative medicine has made significant impacts in cardiovascular research and clinical applications.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Zhihui Zhang embarked on his academic journey with a deep passion for cardiovascular medicine. His early education laid a strong foundation in medical sciences, leading him to specialize in cardiology. His dedication and excellence in research and clinical practice positioned him for advanced studies and significant contributions to the field.

🏥PROFESSIONAL ENDEAVORS:

Dr. Zhang is the Director of the Department of Cardiology at the First Affiliated Hospital (Southwest Hospital) of the Army Medical University in Chongqing. His leadership extends beyond the hospital as he holds multiple prestigious roles:

  • Member of the Great Vessel Group under the Cardiology Branch of the Chinese Medical Association
  • Member of the Cardiologists’ Association of the Chinese Medical Doctor Association
  • Deputy Director of the Committee for Structural Heart Disease under the China Human Health Promotion Association
  • Deputy Director of the Cardiology Branch of the Chongqing Medical Association, leading the Interventional Cardiology and Imaging Group

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIOVASCULAR RESEARCH:

Dr. Zhang is renowned for his expertise in interventional treatment of coronary heart disease and structural heart disease. His research focuses on:

  • Precise diagnosis and treatment of coronary heart disease
  • Interventional therapy for valvular heart diseases
  • Establishing a cohort for precise classification of myocardial ischemia
  • Creating a biobank and an artificial intelligence center for coronary angiography physiological assessment

Additionally, he has developed the professional Circa Met DB database, specializing in metabolic circadian rhythms.

🌍IMPACT AND INFLUENCE:

Dr. Zhang’s contributions have earned him numerous accolades, including:
🏆 Two first prizes for scientific progress in Chongqing
🏆 One first prize for scientific progress in Hubei Province
🏆 One second prize for military medical achievements

He has successfully led over 20 research projects, ranging from national natural science funds to key military and Chongqing talent programs. His pioneering work in cardiology has influenced national and military healthcare policies.

📖ACADEMIC CITATIONS:

Dr. Zhang has an outstanding publication record, with more than 30 SCI papers as the first or corresponding author (including co-first/co-corresponding). His research has been featured in top-tier journals such as:
📌 The Lancet
📌 Nature Metabolism
📌 Nature Communications
📌 Trends in Cell Biology

Additionally, he has contributed to drafting and setting 12 expert consensus documents, served as a deputy editor for two monographs, and contributed to nine other books. His work extends to two national invention patents, further solidifying his impact in the field.

🚀LEGACY AND FUTURE CONTRIBUTIONS:

As a recipient of the Outstanding Youth Talent Fund in National Defense Bioscience, Dr. Zhang is recognized as a key innovator in cardiology. He has been honored as an Innovation Leading Talent by the Chongqing Talents Program and as a Science and Technology Talent by the Army.

His legacy will continue to shape the future of cardiovascular medicine through:
✅ Advanced research in interventional cardiology
✅ Expansion of AI-driven medical diagnostics
✅ Development of groundbreaking therapeutic techniques
✅ Mentorship and training of future cardiologists

🌟CONCLUSION:

Prof. Zhihui Zhang is a visionary leader in cardiology, blending clinical excellence, groundbreaking research, and technological innovation. His contributions have not only transformed patient care but also advanced global medical knowledge. His work will undoubtedly influence generations of medical professionals and redefine the future of cardiovascular treatment.

TOP NOTABLE PUBLICATIONS

Single nucleotide polymorphisms: Implications in the early diagnosis and targeted intervention of coronary microvascular dysfunction

Authors: Dingyuan Tian, Jie Li, Qingyuan Yang, Zhihui Zhang, Fang Deng

Journal: Genes and Diseases

Year: 2025

Circadian nutrition: is meal timing an elixir for fatigue?

Authors: Zhihui Zhang, Lu Yan, Jonas T. Treebak, Min-Dian Li

Journal: Science Bulletin

Year: 2025

Foxo1 drives the TGFβ1-dependent dichotomy of Th17 cell fates

Authors: Mengjuan Zhang, Yude Guan, Meijuan Han, Xiaomin Zhang, Song Zhang

Journal: Journal of Leukocyte Biology

Year: 2025

The short-term outcomes and risk factors of post-myocardial infarction ventricular septal rupture: a multi-center retrospective study

Authors: Wenjian Luo, Li Wen, Jinning Zhang, Zhexue Qin, Shiyong Yu

Journal: Journal of Cardiothoracic Surgery

Year: 2024

Sources and applications of endothelial seed cells: a review

Authors: Dan Deng, Yu Zhang, Bo Tang, Zhihui Zhang

Journal: Stem Cell Research and Therapy

Year: 2024

Enhanced immunosuppressive capability of mesenchymal stem cell-derived small extracellular vesicles with high expression of CD73 in experimental autoimmune uveitis

Authors: Yanan Duan, Xiteng Chen, Hui Shao, Jiawei Wang, Xiaomin Zhang

Journal: Stem Cell Research and Therapy

Year: 2024

Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression

Authors: Junjie Tang, Yaoming Liu, Yinghao Wang, Ping Zhang, Rong Lu

Journal: Biomarker Research

Year: 2024

Associations between non-insulin-based insulin resistance indices and heart failure prevalence in overweight/obesity adults without diabetes mellitus: evidence from the NHANES 2001–2018

Authors: Diyu Cui, Chao Zhang, Yi Chen, Yu Zhang, Ping Zhu

Journal: Lipids in Health and Disease

Year: 2024

Single-cell transcriptomics enable the characterization of local extension in retinoblastoma

Authors: Yaoming Liu, Wei Hu, Yanjie Xie, Shengli Li, Rong Lu

Journal: Communications Biology

Year: 2024

Clinical characteristics of patients with moderate or severe valvular heart disease

Authors: Hao Gao, Yuzhu Lei, Haiyun Huang, Yanxiu Chen, Zhihui Zhang

Journal: Chinese Journal of Cardiology

Year: 2024

Quan Yuan | Cardiovascular| Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Quan Yuan | Cardiovascular | Best Researcher Award 

Prof. QuanYuan, Wuhan University, China

Professor Quan Yuan, a distinguished researcher at Wuhan University, specializes in analytical chemistry with a focus on developing innovative methods for complex sample analysis. His pioneering work includes creating high-sensitivity field-effect transistor-based biosensors for the detection of myocardial injury biomarkers, significantly advancing rapid and accurate heart disease diagnosis. With over 139 journal publications, an H-Index of 41, more than 6,070 citations, 9 patents, and 2 authored books, Professor Yuan’s contributions are widely recognized. As Deputy Editor of “Sensors & Diagnostics” and a key member of multiple professional committees, he exemplifies excellence in research, leadership, and scientific innovation.

Author Profile

Orcid Profile

Education:

Professor Quan Yuan has an outstanding educational background that has shaped his career in analytical chemistry and biosensor technology. He earned his undergraduate degree in Chemistry from a prestigious institution in China, where he developed a strong foundation in chemical principles and experimental techniques. He pursued his master’s degree, specializing in analytical methods, which laid the groundwork for his innovative research. Professor Yuan completed his Ph.D. in Analytical Chemistry, focusing on advanced biosensor development for medical applications. His academic journey reflects a commitment to excellence, equipping him with the expertise to contribute significantly to science, innovation, and education.

Professional Experience:

Professor Quan Yuan has extensive professional experience in both academia and industry. He has led multiple research projects, including the development of highly sensitive biosensors for myocardial injury biomarkers, which have advanced clinical diagnostic methods. As a Deputy Editor for prominent journals such as Sensors & Diagnostics and Chinese Journal of Chemistry, he actively contributes to the scientific community. Professor Yuan has collaborated on various consultancy projects and has worked with leading organizations to translate his research into practical applications. His contributions span across over 6,000 citations and numerous patents, solidifying his reputation as a leading figure in his field.

Research skills:

Professor Quan Yuan possesses exceptional research skills in analytical chemistry and biosensor development. His expertise lies in designing high-sensitivity detection methods, particularly for complex samples such as body fluids and tissues. He has developed a field-effect transistor-based biosensor capable of detecting multiple myocardial injury biomarkers, using advanced machine learning algorithms for risk assessment and prognosis monitoring. His proficiency in integrating circuit technology with biosensors has led to the creation of a portable analysis system for rapid clinical diagnostics. Professor Yuan’s skills in both experimental design and data interpretation, alongside his interdisciplinary approach, have significantly impacted the medical diagnostics field.

Awards and Honors:

Professor Quan Yuan has received numerous awards and honors in recognition of his groundbreaking contributions to analytical chemistry and biomedical diagnostics. His research has earned him significant recognition in the scientific community, including over 6,070 citations and an H-Index of 41. He holds 9 patents and has published extensively in prestigious journals. In addition to his research achievements, Professor Yuan serves as Deputy Editor for “Sensors & Diagnostics” and the “Chinese Journal of Chemistry.” He is actively involved in several professional committees, including the Chinese Chemical Society and the China Medical Equipment Association, showcasing his leadership in advancing scientific innovation.

Conclusion:

Professor Quan Yuan’s exceptional research and groundbreaking innovations in analytical chemistry, particularly in the development of advanced biosensors for heart disease diagnosis, make him a highly deserving candidate for the Best Researcher Award. His pioneering work has not only advanced scientific understanding but also led to practical applications in clinical diagnostics, improving patient care. With a remarkable publication record, numerous patents, and influential roles in editorial and professional committees, Professor Yuan’s leadership in both research and academia has significantly impacted the field. His ongoing contributions continue to shape the future of medical diagnostics and scientific innovation.

Top Notable Publications

Persistent luminescence encoding for rapid and accurate oral-derived bacteria identification

Authors: Not provided

Journal: Chinese Chemical Letters

Year: 2025

Staggered-Stacking Two-Dimensional Covalent Organic Framework Membranes for Molecular and Ionic Sieving

Authors: Not provided

Journal: ACS Nano

Year: 2024

Bio‐Inspired Multiple Responsive NIR II Nanophosphors for Reversible and Environment‐Interactive Information Encryption

Authors: Not provided

Journal: Advanced Materials

Year: 2024

Framework nucleic acid strategy enables closer microbial contact for programming short-range interaction

Authors: Not provided

Journal: Science Advances

Year: 2024

Defect Regulation Strategy of Porous Persistent Phosphors for Multiple and Dynamic Information Encryption

Authors: Not provided

Journal: Small Methods

Year: 2024

DNA Nanomaterial-Based Electrochemical Biosensors for Clinical Diagnosis

Authors: Not provided

Journal: ACS Nano

Year: 2024

Smart Persistent Luminescence Imaging for Early Diagnosis of Drug-Induced Liver Injury

Authors: Not provided

Journal: Chemical & Biomedical Imaging

Year: 2024

Thermodynamics and Kinetics‐Directed Regulation of Nucleic Acid‐Based Molecular Recognition

Authors: Not provided

Journal: Small Methods

Year: 2024

Bionic Potassium Ion Channel in Live Cells Repairs Cardiomyocyte Function

Authors: Not provided

Journal: Journal of the American Chemical Society

Year: 2024

Self‐Powered and Self‐Recoverable Multimodal Force Sensors Based on Trap State and Interfacial Electron Transfer

Authors: Not provided

Journal: Angewandte Chemie International Edition / Angewandte Chemie

Year: 2024